TENCENT
00700
TME-SW
01698
XIAOMI-W
01810
ALI HEALTH
00241
KUAISHOU-W
01024
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 5.74%6.34B | ---- | -55.56%6B | ---- | 84.19%13.5B | ---- | 46.14%7.33B | ---- | 0.92%5.02B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -77.71%-197M | ---- | -67.01%-110.85M | ---- | -75.72%-66.37M | ---- | 58.94%-37.77M | ---- | -29.19%-91.99M |
Interest expense - adjustment | ---- | 35.49%503.41M | ---- | 139.61%371.54M | ---- | -19.56%155.06M | ---- | -29.63%192.77M | ---- | 28.19%273.92M |
Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.17B | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | -9.17%-1.01B | ---- | 22.18%-922.79M | ---- | -5.46%-1.19B | ---- | -75.79%-1.12B | ---- | -13.02%-639.61M |
Impairment and provisions: | ---- | 162.60%9.94M | ---- | -116.96%-15.88M | ---- | 489.45%93.61M | ---- | 219.26%15.88M | ---- | -32.65%4.97M |
-Impairment of trade receivables (reversal) | ---- | -31.61%4.17M | ---- | -76.80%6.09M | ---- | 65.31%26.25M | ---- | --15.88M | ---- | ---- |
-Other impairments and provisions | ---- | 126.28%5.77M | ---- | -132.61%-21.97M | ---- | --67.35M | ---- | ---- | ---- | -32.65%4.97M |
Revaluation surplus: | ---- | 111.60%17.37M | ---- | -2,442.18%-149.69M | ---- | 107.89%6.39M | ---- | 15.78%-81M | ---- | 73.98%-96.18M |
-Fair value of investment properties (increase) | ---- | -39.98%32.25M | ---- | -59.82%53.73M | ---- | 4,238.22%133.71M | ---- | 85.35%-3.23M | ---- | 94.15%-22.06M |
-Other fair value changes | ---- | 92.69%-14.88M | ---- | -59.78%-203.42M | ---- | -63.72%-127.32M | ---- | -4.92%-77.77M | ---- | -1,053.14%-74.12M |
Asset sale loss (gain): | ---- | 2,104.98%84.14M | ---- | -78.63%3.82M | ---- | -75.28%17.86M | ---- | 115.08%72.24M | ---- | -5,019.34%-478.95M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---485.66M |
-Loss (gain) on sale of property, machinery and equipment | ---- | 56.98%84.14M | ---- | -75.33%53.6M | ---- | 322.97%217.29M | ---- | 89.86%51.37M | ---- | 139.97%27.06M |
-Loss (gain) from selling other assets | ---- | ---- | ---- | 75.04%-49.79M | ---- | -1,055.86%-199.43M | ---- | 202.54%20.86M | ---- | -1,221.23%-20.35M |
Depreciation and amortization: | ---- | 1.12%1.51B | ---- | -2.45%1.5B | ---- | 31.05%1.53B | ---- | 8.88%1.17B | ---- | 7.01%1.07B |
-Amortization of intangible assets | ---- | 30.60%3.56M | ---- | 82.42%2.73M | ---- | -16.47%1.5M | ---- | -15.48%1.79M | ---- | -4.33%2.12M |
Special items | ---- | 21.52%102.66M | ---- | 125.69%84.48M | ---- | -838.70%-328.83M | ---- | 141.93%44.51M | ---- | -11,907.79%-106.15M |
Operating profit before the change of operating capital | ---- | 9.08%7.37B | ---- | -50.78%6.76B | ---- | 114.06%13.73B | ---- | 29.38%6.41B | ---- | -4.67%4.96B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 334.37%539.56M | ---- | 78.96%-230.22M | ---- | -430.32%-1.09B | ---- | -3.81%-206.28M | ---- | -1,157.27%-198.7M |
Accounts receivable (increase)decrease | ---- | -252.80%-1.3B | ---- | 232.32%849.43M | ---- | 60.89%-641.94M | ---- | -258.02%-1.64B | ---- | -276.37%-458.47M |
Accounts payable increase (decrease) | ---- | -142.19%-445.43M | ---- | 34.03%1.06B | ---- | 0.51%787.64M | ---- | 100.65%783.67M | ---- | 2,046.18%390.56M |
Cash from business operations | 41.34%2.84B | -26.87%6.17B | -58.42%2.01B | -34.02%8.43B | 47.98%4.83B | 138.92%12.78B | 109.05%3.27B | 14.05%5.35B | -21.68%1.56B | -14.08%4.69B |
Other taxs | -85.79%-525.89M | 56.73%-557.98M | 62.76%-283.06M | 22.28%-1.29B | -12.67%-760.19M | -181.21%-1.66B | -165.95%-674.71M | -4.12%-590.03M | 20.34%-253.7M | -1.93%-566.7M |
Interest paid - operating | 44.77%-170.6M | -50.20%-606.44M | -127.27%-308.88M | -134.98%-403.76M | -78.14%-135.91M | 32.35%-171.83M | 54.01%-76.29M | 26.08%-253.99M | -1.91%-165.88M | -32.69%-343.62M |
Net cash from operations | 51.23%2.14B | -25.77%5B | -63.99%1.42B | -38.46%6.74B | 56.54%3.94B | 143.04%10.95B | 120.10%2.51B | 19.19%4.5B | -24.50%1.14B | -18.60%3.78B |
Cash flow from investment activities | ||||||||||
Interest received - investment | -75.50%27.38M | 77.71%197M | 219.84%111.78M | 67.01%110.85M | 43.94%34.95M | 75.72%66.37M | 14.62%24.28M | -58.94%37.77M | -51.50%21.18M | 29.19%91.99M |
Dividend received - investment | ---- | -15.19%415.25M | ---- | -35.52%489.63M | ---- | 88.85%759.41M | -82.33%36.41M | 76.94%402.13M | --206.1M | -31.44%227.27M |
Loan receivable (increase) decrease | ---280.25M | ---1.32B | ---- | ---- | ---- | -188.81%-29.41M | -90.31%657K | 1,265.69%33.12M | 11,200.00%6.78M | -93.67%2.43M |
Decrease in deposits (increase) | 4.68%1.1B | 183.74%3.49B | 201.61%1.05B | -310.30%-4.17B | 56.57%-1.04B | -6,537.18%-1.02B | -691.35%-2.38B | -130.83%-15.3M | -431.24%-301.27M | 158.14%49.61M |
Sale of fixed assets | ---- | 379.22%151.24M | ---- | 34.94%31.56M | ---- | -18.58%23.39M | ---- | 186.53%28.73M | ---- | -93.05%10.03M |
Purchase of fixed assets | -71.74%-2.47B | -43.30%-2.86B | -99.76%-1.44B | 16.70%-2B | 18.86%-719.74M | 25.05%-2.4B | 37.46%-887.06M | -11.28%-3.2B | -21.13%-1.42B | -63.04%-2.87B |
Purchase of intangible assets | 31.92%-239.21M | 23.80%-509.18M | -108.97%-351.38M | -10.00%-668.23M | 35.48%-168.15M | -41.30%-607.48M | -686.39%-260.61M | -1,049.06%-429.93M | ---33.14M | 92.62%-37.42M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.16B |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---1.35B | ---- | ---- | ---- | ---- |
Recovery of cash from investments | ---- | 44.65%694.03M | 33.58%422.67M | -43.46%479.78M | 4.24%316.42M | 406.21%848.54M | 266.79%303.54M | -69.08%167.63M | 1.30%82.76M | 364.52%542.17M |
Cash on investment | 99.28%-419K | 84.25%-132.86M | 78.72%-58.29M | 36.08%-843.7M | ---273.91M | -99.15%-1.32B | ---- | 46.29%-662.77M | 55.51%-493.31M | -199.21%-1.23B |
Other items in the investment business | -70.69%28.19M | ---- | -3.38%96.18M | ---- | 400.41%99.54M | --4.48M | 7.80%19.89M | ---- | 165.34%18.45M | ---- |
Net cash from investment operations | -1,012.50%-1.83B | 101.86%122.29M | 90.57%-164.7M | -30.81%-6.56B | 44.51%-1.75B | -37.91%-5.02B | -64.69%-3.15B | -76.73%-3.64B | -77.76%-1.91B | -6.02%-2.06B |
Net cash before financing | -75.13%311.58M | 2,835.44%5.12B | -42.79%1.25B | -97.06%174.54M | 446.35%2.19B | 584.26%5.93B | 17.71%-632.35M | -49.64%866.68M | -275.32%-768.39M | -36.30%1.72B |
Cash flow from financing activities | ||||||||||
New borrowing | -9.85%2.98B | 11.01%7.19B | 14.17%3.31B | -31.99%6.48B | 44.48%2.9B | 40.43%9.53B | -46.27%2.01B | 15.98%6.79B | 41.91%3.74B | -16.31%5.85B |
Refund | -1.27%-3.91B | -49.42%-12.58B | -49.11%-3.86B | -49.81%-8.42B | -46.91%-2.59B | 6.68%-5.62B | 46.60%-1.76B | -20.17%-6.02B | -49.89%-3.3B | 8.70%-5.01B |
Issuing shares | -89.81%17.56M | -23.48%171.41M | -6.84%172.37M | 9.39%224M | 14.83%185.02M | 12.16%204.77M | 171.71%161.12M | 33.40%182.57M | -18.64%59.3M | 105.94%136.87M |
Dividends paid - financing | -41.40%-10.97M | 74.12%-946.92M | -48.89%-7.76M | 29.43%-3.66B | -38.43%-5.21M | -173.88%-5.18B | -482.82%-3.77M | 9.22%-1.89B | 48.77%-646K | 1.88%-2.09B |
Absorb investment income | ---- | --329K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | -1,451.27%-1.01B | ---- | -158.07%-65.3M | ---65.3M | 93.18%-25.3M |
Net cash from financing operations | -130.54%-921.08M | -14.41%-6.18B | -183.97%-399.53M | -155.01%-5.4B | 23.10%475.82M | -106.75%-2.12B | -10.02%386.54M | 9.82%-1.02B | -14.50%429.59M | -22.60%-1.14B |
Effect of rate | 82.84%-43.82M | 83.80%-131.5M | 38.86%-255.29M | -594.40%-811.94M | -1,373.31%-417.54M | -46.11%164.23M | 140.72%32.79M | 457.82%304.72M | -1,102.25%-80.54M | 62.10%-85.16M |
Net Cash | -171.42%-609.49M | 79.77%-1.06B | -67.99%853.4M | -237.17%-5.23B | 1,184.56%2.67B | 2,511.08%3.81B | 27.45%-245.81M | -127.04%-158.09M | -136.01%-338.8M | -67.06%584.58M |
Begining period cash | -37.40%1.99B | -65.51%3.18B | -65.51%3.18B | 75.81%9.22B | 75.81%9.22B | 2.88%5.24B | 2.88%5.24B | 10.86%5.1B | 10.86%5.1B | 50.84%4.6B |
Cash at the end | -64.60%1.34B | -37.40%1.99B | -67.06%3.78B | -65.51%3.18B | 127.94%11.47B | 75.81%9.22B | 7.54%5.03B | 2.88%5.24B | -15.44%4.68B | 10.86%5.1B |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.